Janssen Emma B N J, Hooijschuur Mieke C E, Lopes van Balen Veronica A, Morina-Shijaku Erjona, Spaan Julia J, Mulder Eva G, Hoeks Arnold P, Reesink Koen D, van Kuijk Sander M J, Van't Hof Arnoud, van Bussel Bas C T, Spaanderman Marc E A, Ghossein-Doha Chahinda
Department of Obstetrics and Gynaecology, Maastricht University Medical Centre+ (MUMC+), Maastricht, Netherlands.
Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, Netherlands.
Front Cardiovasc Med. 2022 Jul 28;9:911603. doi: 10.3389/fcvm.2022.911603. eCollection 2022.
Preeclampsia, an endothelial disorder of pregnancy, predisposes to remote cardiovascular diseases (CVD). Whether there is an accelerated effect of aging on endothelial decline in former preeclamptic women is unknown. We investigated if the arterial aging regarding endothelial-dependent and -independent vascular function is more pronounced in women with a history of preeclampsia as compared to women with a history of solely normotensive gestation(s).
Data was used from the Queen of Hearts study (ClinicalTrials.gov Identifier NCT02347540); a large cross-sectional study on early detection of cardiovascular disease among young women (≥18 years) with a history of preeclampsia and a control group of low-risk healthy women with a history of uncomplicated pregnancies. Brachial artery flow-mediated dilation (FMD; absolute, relative and allometric) and sublingually administered nitroglycerine-mediated dilation (NGMD; absolute and relative) were measured using ultrasound. Cross-sectional associations of age with FMD and NGMD were investigated by linear regression. Models were adjusted for body mass index, smoking, antihypertensive drug use, mean arterial pressure, fasting glucose, menopausal state, family history of CVD and stress stimulus during measurement. Effect modification by preeclampsia was investigated by including an interaction term between preeclampsia and age in regression models.
Of the 1,217 included women (age range 22-62 years), 66.0% had a history of preeclampsia and 34.0% of normotensive pregnancy. Advancing age was associated with a decrease in relative FMD and NGMD (unadjusted regression coefficient: FMD: -0.48%/10 years (95% CI:-0.65 to -0.30%/10 years), NGMD: -1.13%/10 years (-1.49 to -0.77%/10 years)) and increase in brachial artery diameter [regression coefficient = 0.16 mm/10 years (95% CI 0.13 to 0.19 mm/10 years)]. Similar results were found when evaluating FMD and NGMD as absolute increase or allometrically, and after confounder adjustments. These age-related change were comparable in former preeclamptic women and controls (-values interaction ≥0.372). Preeclampsia itself was independently associated with consistently smaller brachial artery diameter, but not with FMD and NGMD.
In young- to middle-aged women, vascular aging in terms of FMD and NGMD was not accelerated in women after preeclampsia compared to normotensive pregnancies, even though former preeclamptic women consistently have smaller brachial arteries.
子痫前期是一种妊娠期的内皮功能障碍疾病,会增加远期心血管疾病(CVD)的发病风险。既往子痫前期女性的血管内皮功能随年龄增长的下降速度是否加快尚不清楚。我们研究了与仅有血压正常妊娠史的女性相比,有子痫前期病史的女性在血管内皮依赖性和非依赖性血管功能方面的动脉老化是否更明显。
数据来自“红心女王研究”(ClinicalTrials.gov标识符NCT02347540);这是一项针对有子痫前期病史的年轻女性(≥18岁)进行心血管疾病早期检测的大型横断面研究,对照组为有正常妊娠史的低风险健康女性。使用超声测量肱动脉血流介导的血管舒张功能(FMD;绝对值、相对值和异速生长值)以及舌下含服硝酸甘油介导的血管舒张功能(NGMD;绝对值和相对值)。通过线性回归研究年龄与FMD和NGMD的横断面关联。模型对体重指数、吸烟、使用降压药物、平均动脉压、空腹血糖、绝经状态、CVD家族史以及测量期间的应激刺激进行了校正。通过在回归模型中纳入子痫前期与年龄的交互项来研究子痫前期的效应修饰作用。
在纳入研究的1217名女性(年龄范围22 - 62岁)中,66.0%有子痫前期病史,34.0%有血压正常妊娠史。年龄增长与相对FMD和NGMD的降低相关(未校正回归系数:FMD:-0.48%/10年(95%CI:-0.65至-0.30%/10年),NGMD:-1.13%/10年(-1.49至-0.77%/10年)),并且肱动脉直径增加[回归系数 = 0.16 mm/10年(95%CI 0.13至0.19 mm/10年)]。在将FMD和NGMD评估为绝对增加值或异速生长值时,以及在进行混杂因素校正后,发现了类似的结果。这些与年龄相关的变化在既往子痫前期女性和对照组中相当(交互P值≥0.372)。子痫前期本身与始终较小的肱动脉直径独立相关,但与FMD和NGMD无关。
在年轻至中年女性中,与血压正常妊娠的女性相比,子痫前期女性在FMD和NGMD方面的血管老化并未加速,尽管既往子痫前期女性的肱动脉始终较小。